Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Tsutsui, Akemi ^a   Nakanuma, Yasuni ^b,c   Takaguchi, Kouichi ^a   Nakamura, Satoko ^a   Shibata, Hiroshi ^d   Baba, Nobuyuki ^a   Senoh, Tomonori ^a   Nagano, Takuya ^a   Ikeda, Hiroko ^e  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CELL DEGENERATION; CHOLESTASIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE DISEASE WEEK JAPAN 2004 SCALE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER HISTOLOGY; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TOXIC HEPATITIS; VERY ELDERLY; BIOPSY; CHEMICAL AND DRUG INDUCED LIVER INJURY; CLASSIFICATION; COMPARATIVE STUDY; JAPAN; LIVER; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; JAPAN; LIVER; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84964330774     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/913793     Document Type: Article

References (18)

1. R. J. Fontana, L. B. Seeff, R. J. Andrade et al., "Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop," Hepatology, vol. 52, no. 2, pp. 730-742, 2010.
2. G. Ostapowicz, R. J. Fontana, F. V. Schioødt et al., "Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States," Annals of Internal Medicine, vol. 137, no. 12, pp. 947-954, 2002.
3. N. Chalasani and E. Björnsson, "Risk factor for idiosyncratic drug-induced liver injury," Gastroenterology, vol. 138, no. 7, pp. 2246-2259, 2010.
4. M. I. Lucena, M. García-Cortés, R. Cueto, J. Lopez-Duran, and R. J. Andrade, "Assessment of drug-induced liver injury in clinical practice," Fundamental & Clinical Pharmacology, vol. 22, no. 2, pp. 141-158, 2008.
5. J. H. Lewis and E. Kleiner, "Hepatic injury due to drugs, chemicals and toxin," in MacSween's Pathology of the Liver, A. D. Burt, B. C. Portmann, and L. D. Ferrel, Eds., pp. 649-759, EChurchill Livingstone, Elsevier, 2006.
6. K. Tajiri and Y. Shimizu, "Practical guidelines for diagnosis and early management of drug-induced liver injury," World Journal of Gastroenterology, vol. 14, no. 44, pp. 6774-6785, 2008.
7. M. Watanabe, A. Shibuya, Y. Miura et al., "Validity study of DDW-J2004 scoreing scale for drug-induced liver injury," Kanzo, vol. 48, no. 5, pp. 219-226, 2007 (Japanese).
8. T. Hanatani, K. Sai, M. Tohkin et al., "A detection algorithm for drug-induced liver injury in medical information databases using the japanese diagnostic scale and its comparison with the council for international organizations of medical sciences/the roussel uclaf causality assessment method scale," Pharmacoepidemiology and Drug Safety, vol. 23, no. 9, pp. 984-988, 2014.
9. H. Takikawa, M. Onji, Y. Takamori et al., "Proposal of diagnostic criteria of drug induced hepatic injury in DDW-J2004 workshop," Kanzo, vol. 46, no. 2, pp. 85-90, 2005 (Japanese).
10. Y. Nakanuma, "Liver," in Surgical Pathology, K. Mukai, T. Manabe, and M. Fukayama, Eds., pp. 599-664, Bunkodo, 4th edition, 2006.
11. T. Fukusato and M. Oobe, "Drug-induced liver injury," in Basic and Practical Liver Pathology, Y. Nakanuma, Ed., pp. 121-130, Nankodo, 2013.
12. Y. Nakanuma, K. Harada, X. S. Ren et al., "Drug-induced liver injury, pathology," Pathology and Clinical Medicine, vol. 27, no. 8, pp. 764-769, 2009.
13. J. P. Scheuer and J. H. Lefkowitch, "Drugs and toxins," in Liver Biopsy Interpretation, pp. 115-131, Saunders Elsevier, 8th edition, 2010.
14. R. J. Fontana, P. B. Watkins, H. L. Bonkovsky et al., "Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct," Drug Safety, vol. 32, no. 1, pp. 55-68, 2009.
15. D. E. Kleiner, N. P. Chalasani, W. M. Lee et al., "Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations," Hepatology, vol. 59, no. 2, pp. 661-670, 2014.
16. E. Björnsson, J. Talwalkar, S. Treeprasertsuk et al., "Drug-induced autoimmune hepatitis: clinical characteristics and prognosis," Hepatology, vol. 51, no. 6, pp. 2040-2048, 2010.
17. A. Suzuki, E. M. Brunt, D. E. Kleiner et al., "The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury," Hepatology, vol. 54, no. 3, pp. 931-939, 2011.
18. T. J. Davern, N. Chalasani, R. J. Fontana et al., "Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury," Gastroenterology, vol. 141, no. 5, pp. 1665-1672, 2011.